Primary aldosteronism (PA), the most common form of secondary hypertension, can be
either surgically cured or treated with targeted pharmacotherapy. PA is frequently …

Primary aldosteronism is characterized by aldosterone secretion that is independent of renin
and angiotensin II and sodium status. The deleterious effects of primary aldosteronism are …

Objective: To develop clinical practice guidelines for the management of patients with
primary aldosteronism. Participants: The Task Force included a chair, selected by the …

Context: For health care planning and allocation of resources, realistic estimation of the
prevalence of primary aldosteronism is necessary. Reported prevalences of primary …

We are witnessing a revolution in our understanding of primary aldosteronism (PA). In the
past 2 decades, we have learned that PA is a highly prevalent syndrome that is largely …

Objective: Our objective was to develop clinical practice guidelines for the diagnosis and
treatment of patients with primary aldosteronism. Participants: The Task Force comprised a …

Primary aldosteronism (PA) is a common form of endocrine hypertension previously
believed to account for less than 1% of hypertensive patients. Hypokalemia was considered …

AACE= American Association of Clinical Endocrinologists; AAES= American Association of
Endocrine Surgeons; ACC= adrenocortical carcinoma; ACE= angiotensin-converting …

Resistant hypertension is associated with higher rates of cardiovascular disease, kidney
disease, and death than primary hypertension. Although clinical practice guidelines …

Great strides have been made in our understanding of the pathophysiology of primary
aldosteronism syndrome since Conn's description of the clinical presentation of a patient …